Pulmonology and Respiratory Medicine

This speaker became graduate in Chemical Engineering from the University of Santiago de Compostela (Spain) in July 2017. She received the Master Studies Certificate in the Energy Efficiency and Utilization Program, Universidade da Coruna, in August 2018. Currently, she is a PhD student of the Group of Polymers of the Universidade da Coruna, where she is carrying out her doctoral thesis titled "Development of conducting photocurable resins for additive manufacturing" in the area of Applied Physics. The ultimate goal of the project is to obtain low-cost materials 3D printable for electrical applications. She has recently published her first article on this subject in the European Polymer 

Professor Nagy Habib is Head of Surgery at the Hammersmith Campus of Imperial College London and also a serial founder and entrepreneur of life science ventures. He is co-founder of several biotech companies: EMcision Ltd, OmniCyte Ltd, MiNA Therapeutics Ltd, Apterna Ltd, Medeva Plc and Bioenvision Ltd. Previously he was Pro-Rector for Commercial Affairs at Imperial College London. More recently, he has developed a saRNA (a new class of medicines) currently being trialed in patients with liver cancer in eight UK centres, and sites in Singapore and Taiwan